BioMx provides update on defense technology portfolio and growth strategy

BiomX Inc. (NYSE: PHGE) has announced the acceleration of its exclusive option to acquire a controlling interest in DFSL, an Israeli defense engineering company specializing in LADAR-based detection systems for perimeter security, critical infrastructure, and counter-UAS applications. This move represents a strategic expansion into the defense sector, complementing BiomX’s recent acquisition of Zorronet, an AI command-and-control platform. The integration of DFSL’s high-precision LADAR technology with Zorronet’s AI capabilities aims to create a comprehensive detection-to-response security solution.

DFSL’s systems, which have demonstrated approximately 99% accuracy in real-world applications, are designed to reduce false positives and enhance operator effectiveness by combining laser-based sensing with proprietary AI algorithms. The company’s technology is protected by a portfolio of patents and has been deployed globally in critical infrastructure and transportation systems.

The transaction is structured to include cash, an unsecured convertible note, warrants exercisable at $12 per share, and a revenue-based bonus payment. It remains subject to regulatory approval in Israel and shareholder approval on the NYSE American.

BiomX’s growth strategy emphasizes the integration of complementary technologies and the expansion of its defense and security portfolio through strategic acquisitions and partnerships. The company’s leadership highlights the importance of real-world deployment experience and technological innovation in addressing evolving global security needs.